Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 32.20
-0.30 (-0.92%)
Jul 30, 2026, 1:30 PM CST
TPE:1762 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 973.15 | 804.88 | 1,347 | 2,086 | 2,117 | 1,935 |
Revenue Growth | -24.48% | -40.26% | -35.42% | -1.45% | 9.43% | 25.34% |
Gross Profit Gross Profit Growth | 81.19 | -8.86 | 394.32 | 757.31 | 961.76 | 949.39 |
Operating Income Operating Income Growth | -225.35 | -319.54 | 6.34 | 280.81 | 463.53 | 438.48 |
Net Income Net Income Growth | -160.56 | -243.85 | 53.03 | 264.91 | 465.87 | 400.78 |
Earnings Per Share EPS Growth | -2.90 | -4.39 | 0.94 | 3.39 | 5.93 | 5.12 |
EPS Growth | - | - | -72.27% | -42.83% | 15.82% | -24.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Region Taiwan Region Growth | 944.57 | 782.85 | 1,328 | 2,039 | 2,065 | 1,897 |
Adjustment and Write-Off Adjustment and Write-Off Growth | -464.36 | -296.03 | -466.74 | -1,451 | -1,389 | -1,215 |
US Region US Region Growth | 492.94 | 318.06 | 486.51 | 1,498 | 1,441 | 1,253 |
Total Total Growth | 973.15 | 804.88 | 1,347 | 2,086 | 2,117 | 1,935 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 286.49 | 216.44 | 222.28 | 269.57 | 300.61 | 195.25 |
Total Debt Total Debt Growth | 803.94 | 804.57 | 856.89 | 1,208 | 603.26 | 752.34 |
Net Cash (Debt) Net Cash Growth | -517.45 | -588.14 | -634.61 | -938.26 | -302.65 | -557.09 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -9.34 | -10.58 | -11.27 | -12.01 | -3.86 | -7.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 156.27 | 142.61 | 467.65 | -66.27 | 733.78 | 219.18 |
Capital Expenditures CapEx Growth | -40.34 | -61.37 | -103.09 | -450 | -374.66 | -403.36 |
Free Cash Flow Free Cash Flow Growth | 115.93 | 81.24 | 364.57 | -516.27 | 359.12 | -184.18 |
Free Cash Flow Growth | -83.04% | -77.72% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 8.34% | -1.10% | 29.27% | 36.30% | 45.43% | 49.07% |
Operating Margin | -23.16% | -39.70% | 0.47% | 13.46% | 21.89% | 22.66% |
Pretax Margin | -16.25% | -31.77% | 4.25% | 15.98% | 27.55% | 25.72% |
Profit Margin | -16.50% | -30.30% | 3.94% | 12.70% | 22.00% | 20.71% |
FCF Margin | 11.91% | 10.09% | 27.06% | -24.74% | 16.96% | -9.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.192 | - | 0.190 | 0.800 | 1.300 | 1.300 |
Dividend Per Share Growth | -76.05% | - | -76.25% | -38.46% | 0% | -13.33% |
Dividend Yield | 0.59% | - | 0.56% | 1.43% | 2.06% | 2.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 49.58 | 16.81 | 10.92 | 12.56 |
Forward PE | - | 17.28 | 17.28 | 8.11 | 10.40 | 7.96 |
P/FCF Ratio | 21.56 | 23.20 | 7.21 | - | 14.17 | - |
PS Ratio | 2.57 | 2.34 | 1.95 | 2.13 | 2.40 | 2.60 |